OncoCyte Corp (NYSE American:OCX)
| 1.65 Delayed Data As of Oct 23 |  -0.04 / -2.37%Today’s Change | 1.15 Today|||52-Week Range 3.51 | -26.67% Year-to-Date |
Latest OCX News | Press Releases
No recent news for OncoCyte Corp.
Today’s Trading
| Previous close | 1.69 |
| Today’s open | 1.71 |
| Day’s range | 1.62 - 1.71 |
| Volume | 248,924 |
| Average volume (3 months) | 1,287,718 |
| Market cap | $111.6M |
Data as of 4:00pm ET, 10/23/2020
Growth & Valuation
| Earnings growth (last year) | -5.05% |
| Earnings growth (this year) | -2.27% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.07 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ERYPErytech Pharma SA | 0.00 | 0.00% |
| CATBCatabasis Pharmaceut... | -0.11 | -1.86% |
| CRVSCorvus Pharmaceutica... | -0.07 | -1.75% |
| GRTSGritstone Oncology I... | +0.07 | +2.37% |
Data as of 4:37pm ET, 10/23/2020
Financials
| Next reporting date | November 11, 2020 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$22.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
